Ayman Alsebaey

594 total citations
38 papers, 354 citations indexed

About

Ayman Alsebaey is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Ayman Alsebaey has authored 38 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hepatology, 24 papers in Epidemiology and 14 papers in Surgery. Recurrent topics in Ayman Alsebaey's work include Liver Disease and Transplantation (26 papers), Liver Disease Diagnosis and Treatment (24 papers) and Organ Transplantation Techniques and Outcomes (9 papers). Ayman Alsebaey is often cited by papers focused on Liver Disease and Transplantation (26 papers), Liver Disease Diagnosis and Treatment (24 papers) and Organ Transplantation Techniques and Outcomes (9 papers). Ayman Alsebaey collaborates with scholars based in Egypt, Saudi Arabia and United States. Ayman Alsebaey's co-authors include Imam Waked, Eman Rewisha, Maha Elsabaawy, Eman Abdelsameea, Wael Abdel‐Razek, A. Sherif, Mohsen Salama, El-Sayed Ibrahim, Hanaa Badran and Hala El‐Said and has published in prestigious journals such as SHILAP Revista de lepidopterología, Transplantation and Endoscopy.

In The Last Decade

Ayman Alsebaey

37 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayman Alsebaey Egypt 13 249 204 126 47 30 38 354
Alessandra Mazzola Italy 12 182 0.7× 112 0.5× 102 0.8× 36 0.8× 54 1.8× 25 377
Carine Chagneau-Derrode France 8 348 1.4× 331 1.6× 268 2.1× 16 0.3× 21 0.7× 14 457
Ali Tüzün Türkiye 11 141 0.6× 186 0.9× 100 0.8× 27 0.6× 38 1.3× 25 339
Andrea Brunati Italy 15 283 1.1× 185 0.9× 378 3.0× 51 1.1× 24 0.8× 31 536
Urszula Ołdakowska‐Jedynak Poland 11 87 0.3× 71 0.3× 97 0.8× 35 0.7× 33 1.1× 36 305
Apurva Shah India 10 105 0.4× 136 0.7× 54 0.4× 25 0.5× 23 0.8× 26 250
Maria Lúcia Zanotelli Brazil 15 349 1.4× 173 0.8× 332 2.6× 25 0.5× 33 1.1× 44 481
Shinji Uemoto Japan 9 200 0.8× 103 0.5× 243 1.9× 35 0.7× 13 0.4× 11 439
Mohamed Safwan United States 14 301 1.2× 206 1.0× 400 3.2× 102 2.2× 29 1.0× 40 532
Myung Seok Lee South Korea 12 197 0.8× 188 0.9× 78 0.6× 73 1.6× 29 1.0× 37 351

Countries citing papers authored by Ayman Alsebaey

Since Specialization
Citations

This map shows the geographic impact of Ayman Alsebaey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayman Alsebaey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayman Alsebaey more than expected).

Fields of papers citing papers by Ayman Alsebaey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayman Alsebaey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayman Alsebaey. The network helps show where Ayman Alsebaey may publish in the future.

Co-authorship network of co-authors of Ayman Alsebaey

This figure shows the co-authorship network connecting the top 25 collaborators of Ayman Alsebaey. A scholar is included among the top collaborators of Ayman Alsebaey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayman Alsebaey. Ayman Alsebaey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alsebaey, Ayman, et al.. (2021). IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients. Expert Review of Anti-infective Therapy. 20(1). 121–129. 1 indexed citations
2.
Abdelsameea, Eman, et al.. (2020). Direct acting antivirals are associated with more liver stiffness regression than pegylated interferon therapy in chronic hepatitis C patients. Expert Review of Anti-infective Therapy. 19(8). 1053–1059. 6 indexed citations
3.
Alsebaey, Ayman, et al.. (2020). Laparoscopic cholecystectomy in patients with liver cirrhosis: 8 years experience in a tertiary center. A retrospective cohort study. Annals of Medicine and Surgery. 51. 1–10. 14 indexed citations
4.
Badran, Hanaa, et al.. (2020). Baseline Sarcopenia is Associated with Lack of Response to Therapy, Liver Decompensation and High Mortality in Hepatocellular Carcinoma Patients. Asian Pacific Journal of Cancer Prevention. 21(11). 3285–3290. 14 indexed citations
5.
Alsebaey, Ayman, et al.. (2020). Ascitic calprotectin as a useful marker in the diagnosis of spontaneous bacterial peritonitis in adults. SHILAP Revista de lepidopterología. 10(1). 6 indexed citations
6.
7.
Zakaria, Hazem, et al.. (2019). Surgical (Open and laparoscopic) management of large difficult CBD stones after different sessions of endoscopic failure: A retrospective cohort study. Annals of Medicine and Surgery. 43. 52–63. 13 indexed citations
8.
Salman, Ahmed, Ahmed Hamdy, Mohammed Ewid, et al.. (2019). Predictive value of omental thickness on ultrasonography for diagnosis of unexplained ascites, an Egyptian centre study. Asian Journal of Surgery. 43(1). 13–19. 5 indexed citations
9.
Alsebaey, Ayman, et al.. (2019). Insulin resistance is not a risk factor for oesophageal varices development in hepatitis C. Tropical Doctor. 49(4). 281–285. 1 indexed citations
10.
11.
Alsebaey, Ayman, et al.. (2019). Predictors of early recipient mortality after living donor liver transplantation in a tertiary care center in Egypt. Annals of Saudi Medicine. 39(5). 337–344. 2 indexed citations
12.
Alsebaey, Ayman, et al.. (2018). High efficacy of generic and brand direct acting antivirals in treatment of chronic hepatitis C. International Journal of Infectious Diseases. 75. 109–114. 37 indexed citations
13.
Alsebaey, Ayman, et al.. (2018). Efficacy and safety of basiliximab as initial immunosuppression in liver transplantation: A single center study. Annals of Hepatology. 19(5). 541–545. 9 indexed citations
14.
Abdel‐Razek, Wael, et al.. (2018). Insulin resistance does not impair response of chronic hepatitis C virus to direct-acting antivirals, and improves with the treatment. European Journal of Gastroenterology & Hepatology. 31(1). 16–23. 15 indexed citations
15.
Alsebaey, Ayman, et al.. (2017). Platelets-to-lymphocyte ratio is a good predictor of liver fibrosis and insulin resistance in hepatitis C virus-related liver disease. European Journal of Gastroenterology & Hepatology. 30(2). 207–211. 24 indexed citations
16.
Atef, Mohammed, et al.. (2017). Combined spontaneous bacterial empyema and peritonitis in cirrhotic patients with ascites and hepatic hydrothorax. Arab Journal of Gastroenterology. 18(2). 104–107. 11 indexed citations
17.
Alsebaey, Ayman, et al.. (2015). Complications and mortality after adult to adult living donor liver transplantation: A retrospective cohort study. Annals of Medicine and Surgery. 4(2). 162–171. 31 indexed citations
18.
Alsebaey, Ayman. (2015). Normal liver stiffness: A study in living donors with normal liver histology. World Journal of Hepatology. 7(8). 1149–1149. 14 indexed citations
19.
Elsabaawy, Maha, et al.. (2015). The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction. Clinical and Molecular Hepatology. 21(4). 365–365. 12 indexed citations
20.
Alsebaey, Ayman, et al.. (2015). Neutrophil Gelatinase-Associated Lipocalin: A New Marker of Renal Function in C-Related End Stage Liver Disease. Gastroenterology Research and Practice. 2015. 1–6. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandra Mazzola Breakdown of academic impact, for papers by Carine Chagneau-Derrode Breakdown of academic impact, for papers by Ali Tüzün Breakdown of academic impact, for papers by Andrea Brunati Breakdown of academic impact, for papers by Urszula Ołdakowska‐Jedynak Breakdown of academic impact, for papers by Apurva Shah Breakdown of academic impact, for papers by Maria Lúcia Zanotelli Breakdown of academic impact, for papers by Shinji Uemoto Breakdown of academic impact, for papers by Mohamed Safwan Breakdown of academic impact, for papers by Myung Seok Lee
Rankless by CCL
2026